LSD1-IN-33
LSD1-IN-33 (7d), an orally active LSD1 inhibitor with an IC50 of 4.51 nM, alleviates Ang II-induced NRCFs activation in vitro and reducing pathological myocardial remodeling in TAC-induced cardiac remodeling and heart failure in vivo.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 3048029-42-8
- Formule: C19H16F2N4O2
- Masse moléculaire:370.35
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Chemical Information
-
CAS No. 3048029-42-8
-
Masse moléculaire 370.35
-
Formule C19H16F2N4O2
-
SMILES
FC1=CC([C@@H]2C[C@H]2NCC3=CN(N=N3)C4=CC=C5OCOC5=C4)=CC=C1F
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)